← FDA DRUG APPROVALS

FDA ANDA · ANDA091596

TRANEXAMIC ACID

Sponsor: FRESENIUS KABI USA

APPLICATION
ANDA091596
TYPE
ANDA
ORIGINAL APPROVAL
2012-03-02
LATEST ACTION
2021-06-24
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

TRANEXAMIC ACIDDiscontinued
TRANEXAMIC ACID 100MG/ML · INJECTABLE · INJECTION

Approval history

2021-06-24Labeling · Supplement 5 · standardAP
2019-08-14Labeling · Supplement 4 · standardAP
2016-02-19Labeling · Supplement 2 · standardAP
2012-03-02Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →